АФФЕКТИВНЫЕ И ТРЕВОЖНЫЕ НАРУШЕНИЯ В КОЛОПРОКТОЛОГИЧЕСКОЙ ПРАКТИКЕ (НАУЧНЫЙ ОБЗОР)

Roman Aleksandrovich Bekker, Yuriy Vitalevich Bykov


Аннотация


Цель исследования: Представить читателю подробный обзор распространённости аффективных и тревожных нарушений в колопроктологической практике, а также коморбидных с депрессивными и тревожными нарушениями колопроктологических заболеваний (в частности, таких типичных для депрессии, как хронические запоры), гипотезы о механизмах двусторонней патофизиологической связи депрессивных и тревожных нарушений с колопроктологическими заболеваниями, а также обзор того, как психотропные лекарства могут влиять на функцию толстой кишки в положительную (терапевтически полезную) или отрицательную (способствующую колопроктологическим заболеваниям) сторону, и как традиционно применяемые в колопроктологии лекарства и методы лечения могут, в свою очередь, влиять на состояние психики в обе стороны, и представить вытекающие из этого стратегии одновременного лечения как психических, так и колопроктологических заболеваний.

Методология проведения работы: Авторами был проведён поиск литературы о связи колопроктологических заболеваний, таких, как болезнь Крона, неспецифический язвенный колит, запоры, анальные трещины и др., с депрессивными и тревожными состояниями, с использованием соответствующих ключевых слов, в поисковых системах PubMed и Google Scholar. Затем авторами был проведён поиск литературы о психиатрических осложнениях применяемых в колопроктологии лекарств и методов лечения и о применении их с терапевтическими целями в психиатрии, а также о применении антидепрессантов, анксиолитиков и других психотропных лекарств в колопроктологии.

Результаты: Полученные в результате этого обзора данные свидетельствуют о тесной двусторонней связи депрессивных и тревожных состояний с функцией толстого кишечника и с целым рядом колопроктологических заболеваний, а также о перспективности использования некоторых колопроктологических лекарств и методов лечения (например, антицитокиновых препаратов, пробиотиков, аминосалицилатов, трансплантации фекальной микробиоты) в психиатрии, а психотропных лекарств – при ряде колопроктологических заболеваний, и о необходимости уделять большее внимание выявлению и лечению коморбидных депрессивных и тревожных состояний у колопроктологических больных, и колопроктологических проблем, таких, как хронические запоры или дисбактериоз кишечника, у депрессивных и тревожных больных.

Область применения результатов: Полученные нами данные заслуживают самого широкого применения как в колопроктологической, так и в психиатрической практике.


Ключевые слова


депрессия; тревога; запоры; геморрой; воспалительные заболевания кишечника; злокачественные опухоли кишечника; анизм; цитокины; дисбактериоз кишечника; пробиотики; антицитокиновая терапия; аминосалицилаты; трансплантация фекальной микробиоты

Полный текст:

PDF>PDF

Литература


Быков Ю.В., Беккер Р.А., Резников М.К. Депрессии и резистентность (практическое руководство). М.: ИНФРА-М., 2013.

Abautret-Daly Á. et al. Gut–brain actions underlying comorbid anxiety and depression associated with inflammatory bowel disease //Acta Neuropsychiatrica. 2017. С. 1–22.

Abdel-Salam O.M.E., Baiuomy A.R., Arbid M.S. Studies on the anti-inflammatory effect of fluoxetine in the rat //Pharmacological Research. 2004. Т. 49. №. 2. С. 119–131.

Addolorato G. et al. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status //Scandinavian journal of gastroenterology. 1997. Т. 32. №. 10. С. 1013–1021.

Akil H. et al. Tropomyosin-related kinase B/brain derived-neurotrophic factor signaling pathway as a potential therapeutic target for colorectal cancer //World journal of gastroenterology. 2016. Т. 22. №. 2. С. 490–500.

Allen-Mersh T.G. et al. Relation between depression and circulating immune products in patients with advanced colorectal cancer //Journal of the Royal Society of Medicine. 1998. Т. 91. №. 8. С. 408–413.

Archer J.A. et al. Interrelationship of depression, stress and inflammation in cancer patients: a preliminary study //Journal of affective disorders. 2012. Т. 143. №. 1. С. 39–46.

Aricioğlu F. et al. Evaluation of antinociceptive and anti-inflammatory effects of venlafaxine in the rat //Agri: Agri (Algoloji) Dernegi’nin Yayin organidir= The journal of the Turkish Society of Algology. 2005. Т. 17. №. 4. С. 41–46.

Arısoy Ö., Şengül N., Çakir A. Stress and psychopathology and its impact on quality of life in chronic anal fissure (CAF) patients //International journal of colorectal disease. 2017. Т. 32. №. 6. С. 921–924.

Atkin G.K., Suliman A., Vaizey C.J. Patient characteristics and treatment outcome in functional anorectal pain //Diseases of the Colon & Rectum. 2011. Т. 54. №. 7. С. 870–875.

Battaglia T.A. et al. Beliefs About Anal Cancer among HIV-Infected Women: Barriers and Motivators to Participation in Research //Women’s Health Issues. 2015. Т. 25. №. 6. С. 720–726.

Beck D.E. et al. (ed.). The ASCRS textbook of colon and rectal surgery. Springer Science & Business Media, 2011.

Benedict C. et al. Investigation of body image as a mediator of the effects of bowel and GI symptoms on psychological distress in female survivors of rectal and anal cancer //Supportive Care in Cancer. 2016. Т. 24. №. 4. С. 1795–1802.

Bentzen A.G. et al. Impaired health-related quality of life after chemoradiotherapy for anal cancer: late effects in a national cohort of 128 survivors //Acta Oncologica. 2013. Т. 52. №. 4. С. 736–744.

Bogaczewicz J. et al. Exacerbations of bipolar disorder triggered by chloroquine in systemic lupus erythematosus – a case report //Lupus. 2014. Т. 23. №. 2. С. 188-193.

Borre Y.E. et al. Microbiota and neurodevelopmental windows: implications for brain disorders //Trends in molecular medicine. 2014. Т. 20. №. 9. С. 509–518.

Bosma E. et al. Health status, anxiety, and depressive symptoms following complicated and uncomplicated colorectal surgeries // International journal of colorectal disease. 2016. Т. 31. №. 2. С. 273–282.

Bottino S. M. B., Fráguas R., Gattaz W.F. Depression and cancer //Archives of Clinical Psychiatry (São Paulo). 2009. Т. 36. С. 109–115.

Bouchoucha M., Devroede G., Arsac M. Anismus: a marker of multi-site functional disorders? //International journal of colorectal disease. 2004. Т. 19. №. 4. С. 374–379.

Bruce-Keller A. J., Salbaum J. M., Berthoud H. R. Harnessing Gut Microbes for Mental Health: Getting From Here to There //Biological psychiatry. 2017. pii: S0006-3223(17)31902-9.

Canli T. Reconceptualizing major depressive disorder as an infectious disease //Biology of mood & anxiety disorders. 2014. Т. 4. №. 1. С. 10.

Carmack C. L. et al. Feasibility of an expressive‐disclosure group intervention for post-treatment colorectal cancer patients //Cancer. 2011. Т. 117. №. 21. С. 4993-5002.

Cioli V. M., Gagliardi G., Pescatori M. Psychological stress in patients with anal fistula //International journal of colorectal disease. 2015. Т. 30. №. 8. С. 1123–1129.

de Farias C. B. et al. BDNF/TrkB signaling protects HT-29 human colon cancer cells from EGFR inhibition // Biochemical and biophysical research communications. 2012. Т. 425. №. 2. С. 328–332.

de Oliveira Ribeiro N. P. et al. Anxiety, depression and suicidal ideation in patients with rheumatoid arthritis in use of methotrexate, hydroxychloroquine, leflunomide and biological drugs // Comprehensive psychiatry. 2013. Т. 54. №. 8. С. 1185–1189.

De Winter B. Y. et al. Effect of ghrelin and growth hormone-releasing peptide 6 on septic ileus in mice //Neurogastroenterology & Motility. 2004. Т. 16. №. 4. С. 439–446.

Del Popolo F. et al. Psycho-echo-biofeedback: a novel treatment for anismus – results of a prospective controlled study // Techniques in coloproctology. 2014. Т. 18. №. 10. С. 895-900.

Deter H. C. et al. High-utilizing Crohn’s disease patients under psychosomatic therapy //BioPsychoSocial medicine. 2008. Т. 2. №. 1. С. 18.

Devanarayana N. M. et al. Abdominal pain–predominant functional gastrointestinal diseases in children and adolescents: prevalence, symptomatology, and association with emotional stress //Journal of pediatric gastroenterology and nutrition. 2011. Т. 53. №. 6. С. 659–665.

Drossman D. A. et al. Psychosocial aspects of the functional gastrointestinal disorders // Gut. 1999. Т. 45. №. suppl 2. С. II25-II30.

Dunn J. et al. Dimensions of quality of life and psychosocial variables most salient to colorectal cancer patients // Psycho-Oncology. 2006. Т. 15. №. 1. С. 20–30.

Elderon L., Whooley M. A. Depression and cardiovascular disease //Progress in cardiovascular diseases. 2013. Т. 55. №. 6. С. 511–523.

Emmanuel A., Quigley E. M. M. (ed.). Irritable bowel syndrome: diagnosis and clinical management. John Wiley & Sons, 2013.

Emmertsen K. J., Laurberg S. Impact of bowel dysfunction on quality of life after sphincter‐preserving resection for rectal cancer //British Journal of Surgery. 2013. Т. 100. №. 10. С. 1377–1387.

Eshuis E. J. et al. Suicide attempt in ulcerative colitis patient after 4 months of infliximab therapy – a case report // Journal of Crohn’s and Colitis. 2010. Т. 4. №. 5. С. 591–593.

Evrensel A., Ceylan M. E. The Gut-Brain Axis: The Missing Link in Depression //Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. 2015. Т. 13. №. 3. С. 239–244.

Filipovic B. R., Filipovic B. F. Psychiatric comorbidity in the treatment of patients with inflammatory bowel disease // World journal of gastroenterology. 2014. Т. 20. №. 13. С. 3552–3563.

Fingeret M. C., Teo I., Epner D. E. Managing body image difficulties of adult cancer patients: lessons from available research // Cancer. 2014. Т. 120. №. 5. С. 633–641.

Fitzgerald P. et al. Tryptophan catabolism in females with irritable bowel syndrome: relationship to interferon-gamma, severity of symptoms and psychiatric co-morbidity //Neurogastroenterology & Motility. 2008. Т. 20. №. 12. С. 1291–1297.

Fletcher B. C. et al. Eating disorders and concurrent psychopathology: a reconceptualisation of clinical need through Rasch analysis //European Eating Disorders Review. 2008. Т. 16. №. 3. С. 191–198.

Ghia J. E., Blennerhassett P., Collins S. M. Impaired parasympathetic function increases susceptibility to inflammatory bowel disease in a mouse model of depression //The Journal of clinical investigation. 2008. Т. 118. №. 6. С. 2209–2218.

Good M. I., Shader R. I. Lethality and behavioral side effects of chloroquine //Journal of clinical psychopharmacology. 1982. Т. 2. №. 1. С. 40–47.

Graff L. A., Walker J. R., Bernstein C. N. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management //Inflammatory bowel diseases. 2009. Т. 15. №. 7. С. 1105–1118.

Grano C. et al. Feelings of depression in people with arm: The role of critical incidents and perceived difficulties in close and sexual relationships //Pediatric surgery international. 2014. Т. 30. №. 8. С. 823–828.

Greenbaum D. S. et al. Effects of desipramine on irritable bowel syndrome compared with atropine and placebo //Digestive diseases and sciences. 1987. Т. 32. №. 3. С. 257–266.

Griffiths C. E. M. et al. Impact of Ixekizumab Treatment on Depressive Symptoms and Systemic Inflammation in Patients with Moderate-to-Severe Psoriasis: An Integrated Analysis of Three Phase 3 Clinical Studies //Psychotherapy and psychosomatics. 2017. Т. 86. №. 5. С. 260–267.

Gupta R. K. Major depression: an illness with objective physical signs //The World Journal of Biological Psychiatry. 2009. Т. 10. №. 3. С. 196–201.

Hajhashemi V. et al. Central and peripheral anti-inflammatory effects of maprotiline on carrageenan-induced paw edema in rats //Inflammation research. 2010. Т. 59. №. 12. С. 1053–1059.

Hariram J., Jegan Y. Contribution of methotrexate in precipitation of manic episode in bipolar affective disorder explored: a case report //Therapeutic advances in psychopharmacology. 2013. Т. 3. №. 4. С. 251–254.

Hosseinzadeh S. T. et al. Psychological disorders in patients with chronic constipation // Gastroenterology and hepatology from bed to bench. 2011. Т. 4. №. 3. С. 159–163.

Illman J. et al. Are inflammatory cytokines the common link between cancer-associated cachexia and depression? //Journal of Supportive Oncology. 2005. Т. 3. №. 1. С. 37–50.

Jain R., Jain S. Anti-depressants in the treatment of chronic pain //Pract Pain Manag. 2011. Т. 11. С. 1–12.

Jia Y. et al. Depression and cancer risk: a systematic review and meta-analysis //Public health. 2017. Т. 149. С. 138–148.

Juncadella A. C., Moss A. Fecal microbiota transplantation as a possible treatment of irritable bowel syndrome //Annals of translational medicine. 2017. Т. 5. №. 24. С. 506.

Kaidar-Person O., Person B., Wexner S. D. Hemorrhoidal disease: a comprehensive review //Journal of the American College of Surgeons. 2007. Т. 204. №. 1. С. 102–117.

Kang Y., Cai Y. Gut microbiota and obesity: implications for fecal microbiota transplantation therapy //Hormones (Athens, Greece). 2017. Т. 16. №. 3. С. 223–234.

Kappelmann N. et al. Antidepressant activity of anti-cytokine treatment: a systematic review and meta-analysis of clinical trials of chronic inflammatory conditions // Molecular psychiatry. 2016.

Kelly J. R. et al. Transferring the blues: depression-associated gut microbiota induces neurobehavioural changes in the rat // Journal of psychiatric research. 2016. Т. 82. С. 109–118.

Kootte R. S. et al. Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition //Cell metabolism. 2017. Т. 26. №. 4. С. 611–619. e6.

Kopp M. V. et al. Lactobacillus GG has in vitro effects on enhanced interleukin-10 and interferon-γ release of mononuclear cells but no in vivo effects in supplemented mothers and their neonates //Clinical & Experimental Allergy. 2008. Т. 38. №. 4. С. 602–610.

Kukla U. et al. Mental disorders in digestive system diseases-internist’s and psychiatrist’s insight // Polski merkuriusz lekarski: organ Polskiego Towarzystwa Lekarskiego. 2015. Т. 38. №. 227. С. 245–249.

Kurina L. M. et al. Depression and anxiety in people with inflammatory bowel disease // Journal of Epidemiology & Community Health. 2001. Т. 55. №. 10. С. 716–720.

Levkovich T. et al. Probiotic bacteria induce a ‘glow of health’ //PloS one. 2013. Т. 8. №. 1. С. e53867.

Li J. et al. Gut microbiota dysbiosis contributes to the development of hypertension // Microbiome. 2017. Т. 5. №. 1. С. 14.

Livovsky D. M. et al. Tricyclic antidepressants for the treatment of tenesmus associated with rectal prolapse //Colorectal Disease. 2015. Т. 17. №. 12. С. 1094–1099.

Lorenzo-Rivero S. Hemorrhoids: diagnosis and current management //The American surgeon. 2009. Т. 75. №. 8. С. 635–642.

Ma M. et al. Effects of Brilliant Blue G on Serum Tumor Necrosis Factor-α Levels and Depression-like Behavior in Mice after Lipopolysaccharide Administration //Clinical psychopharmacology and neuroscience: the official scientific journal of the Korean College of Neuropsychopharmacology. 2014. Т. 12. №. 1. С. 31–36.

Maes M. et al. The negative immunoregulatory effects of fluoxetine in relation to the cAMP-dependent PKA pathway //International immunopharmacology. 2005. Т. 5. №. 3. С. 609–618.

Magni G. et al. Psychological findings in chronic anal pain //Psychopathology. 1986. Т. 19. №. 4. С. 170–174.

Mangiola F. et al. Gut microbiota in autism and mood disorders //World Journal of Gastroenterology. 2016. Т. 22. №. 1. С. 361–368.

Mapel D. W., Schum M., Von Worley A. The epidemiology and treatment of anal fissures in a population-based cohort // BMC gastroenterology. 2014. Т. 14. №. 1. С. 129.

Massetti G. M. et al. Mental health problems and cancer risk factors among young adults //American journal of preventive medicine. 2017. Т. 53. №. 3. С. S30-S39.

Mayer E. A. Gut feelings: the emerging biology of gut–brain communication //Nature Reviews Neuroscience. 2011. Т. 12. №. 8. С. 453–466.

McNutt M. D. et al. Neurobehavioral effects of interferon-α in patients with hepatitis-C: symptom dimensions and responsiveness to paroxetine //Neuropsychopharmacology. 2012. Т. 37. №. 6. С. 1444–1454.

Medeiros M., Oshima C. T. F., Forones N. M. Depression and anxiety in colorectal cancer patients //Journal of gastrointestinal cancer. 2010. Т. 41. №. 3. С. 179–184.

Mikocka-Walus A. et al. Symptoms of depression and anxiety are independently associated with clinical recurrence of inflammatory bowel disease //Clinical gastroenterology and hepatology. 2016. Т. 14. №. 6. С. 829–835. e1.

Milne B., Joachim G., Niedhardt J. A stress management programme for inflammatory bowel disease patients //Journal of advanced nursing. 1986. Т. 11. №. 5. С. 561–567.

Mittermaier C. et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study //Psychosomatic medicine. 2004. Т. 66. №. 1. С. 79–84.

Musselman D. L. et al. Higher than normal plasma interleukin-6 concentrations in cancer patients with depression: preliminary findings //American Journal of Psychiatry. 2001. Т. 158. №. 8. С. 1252–1257.

Nashed M. G. et al. Behavioural Effects of Using Sulfasalazine to Inhibit Glutamate Released by Cancer Cells: A Novel target for Cancer-Induced Depression // Scientific reports. 2017. Т. 7. С. 41382.

North C. S., Hong B. A., Alpers D. H. Relationship of functional gastrointestinal disorders and psychiatric disorders: implications for treatment //World journal of gastroenterology. 2007. Т. 13. №. 14. С. 2020–2027.

Nowakowski J., Chrobak A. A., Dudek D. Psychiatric illnesses in inflammatory bowel diseases–psychiatric comorbidity and biological underpinnings //Psychiatr. Pol. 2016. Т. 50. №. 6. С. 1157–1166.

O’Mahony S. M. et al. 5-HT (2B) receptors modulate visceral hypersensitivity in a stress-sensitive animal model of brain-gut axis dysfunction //Neurogastroenterology and motility: the official journal of the European Gastrointestinal Motility Society. 2010. Т. 22. №. 5. С. 573–578, e124.

O’Mahony S. M. et al. Early life stress alters behavior, immunity, and microbiota in rats: implications for irritable bowel syndrome and psychiatric illnesses //Biological psychiatry. 2009. Т. 65. №. 3. С. 263–267.

Ooijevaar R. E. et al. Update of treatment algorithms for Clostridium difficile infection //Clinical Microbiology and Infection. 2018. pii: S1198-743X(18)30021-1.

Parashar A., Udayabanu M. Gut microbiota: Implications in Parkinson’s disease //Parkinsonism & Related Disorders. 2017. Т. 38. С. 1–7.

Persoons P. et al. The impact of major depressive disorder on the short‐and long-term outcome of Crohn’s disease treatment with infliximab //Alimentary pharmacology & therapeutics. 2005. Т. 22. №. 2. С. 101–110.

Petra A. I. et al. Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation //Clinical therapeutics. 2015. Т. 37. №. 5. С. 984–995.

Purim O., Gordon N., Brenner B. Cancer of the colon and rectum: potential effects of sex-age interactions on incidence and outcome //Medical science monitor: international medical journal of experimental and clinical research. 2012. Т. 19. С. 203–209.

Pyter L. M. et al. Peripheral tumors induce depressive-like behaviors and cytokine production and alter hypothalamic-pituitary-adrenal axis regulation //Proceedings of the National Academy of Sciences. 2009. Т. 106. №. 22. С. 9069–9074.

Rebrov V. G., Lukomskiĭ M. I. A case of depression in the treatment of nonspecific ulcerative colitis with sulfasalazine //Klinicheskaia meditsina. 1989. Т. 67. №. 8. С. 106.

Renzi C., Pescatori M. Psychologic aspects in proctalgia //Diseases of the colon & rectum. 2000. Т. 43. №. 4. С. 535–539.

Rich T. et al. Elevated serum cytokines correlated with altered behavior, serum cortisol rhythm, and dampened 24-hour rest-activity patterns in patients with metastatic colorectal cancer //Clinical cancer research. 2005. Т. 11. №. 5. С. 1757–1764.

Rosenfeld C. S. Microbiome Disturbances and Autism Spectrum Disorders //Drug metabolism and disposition: the biological fate of chemicals. 2015. Т. 43. №. 10. С. 1557–1571.

Sadeghi H. et al. A study on the mechanisms involving the anti-inflammatory effect of amitriptyline in carrageenan-induced paw edema in rats //European journal of pharmacology. 2011. Т. 667. №. 1. С. 396–401.

Sajadinejad M. S. et al. Psychological issues in inflammatory bowel disease: an overview //Gastroenterology research and practice. 2011. Т. 2012. С. 106502.

Scarlett Y. Medical management of fecal incontinence //Gastroenterology. 2004. Т. 126. С. S55–S63.

Scherer J. Depression induced by salazosulfapyridine in cyclothymia and Crohn disease //Der Nervenarzt. 1988. Т. 59. №. 6. С. 371–373.

Sertbas Y. et al. Assesment of psychiatric symptoms and co-morbidities in patients with irritable bowel syndrome //West Indian Medical Journal. 2012. Т. 61. №. 5. С. 544–548.

Seruga B. et al. Cytokines and their relationship to the symptoms and outcome of cancer //Nature Reviews Cancer. 2008. Т. 8. №. 11. С. 887-899.

Soares de Lima T. A. et al. Proinflammatory cytokines correlate with depression and anxiety in colorectal cancer patients //BioMed research international. 2014. Т. 2014. С. 739650.

Späth-Schwalbe E. et al. Acute effects of recombinant human interleukin-6 on endocrine and central nervous sleep functions in healthy men //The Journal of Clinical Endocrinology & Metabolism. 1998. Т. 83. №. 5. С. 1573–1579.

Stahl S. M. Stahl’s essential psychopharmacology: neuroscientific basis and practical applications. Cambridge university press, 2013.

Staller K. et al. Depression but Not Symptom Severity is Associated With Work and School Absenteeism in Refractory Chronic Constipation //Journal of clinical gastroenterology. 2017.

Taché Y., Bernstein C. N. Evidence for the role of the brain-gut axis in inflammatory bowel disease: depression as cause and effect? //Gastroenterology. 2009. Т. 136. №. 7. С. 2058–2061.

Taché Y., Kiank C., Stengel A. A role for corticotropin-releasing factor in functional gastrointestinal disorders //Current gastroenterology reports. 2009. Т. 11. №. 4. С. 270–277.

Tamaji A. et al. Differential effects of diazepam, tandospirone, and paroxetine on plasma brain-derived neurotrophic factor level under mental stress //Human Psychopharmacology: Clinical and Experimental. 2012. Т. 27. №. 3. С. 329–333.

Tanaka K. et al. Brain-derived neurotrophic factor (BDNF)-induced tropomyosin-related kinase B (Trk B) signaling is a potential therapeutic target for peritoneal carcinomatosis arising from colorectal cancer //PloS one. 2013. Т. 9. №. 5. С. e96410.

Taylor C., Bradshaw E. Tied to the toilet: lived experiences of altered bowel function (anterior resection syndrome) after temporary stoma reversal //Journal of Wound Ostomy & Continence Nursing. 2013. Т. 40. №. 4. С. 415–421.

Teunissen S, da Graeff, Voest E. Are anxiety and depressed mood related to physical symptom: a study in hospitalized advanced cancer patients. Palliative Mdicine. 2007;21:341–346.

Thong MS, Mols F, Lemmens VE et al. Impact of preoperative radiotherapy on general and disease-specific health status of rectal cancer survivors: a population-based study. Int J Radiat Oncol Biol Phys. 2011;81:49–58.

Tsunoda A. et al. Anxiety, depression and quality of life in colorectal cancer patients //International journal of clinical oncology. 2005. Т. 10. №. 6. С. 411–417.

Udina M. et al. Interferon-induced depression in chronic hepatitis C: a systematic review and meta-analysis //The Journal of clinical psychiatry. 2012. Т. 73. №. 8. С. 1128–1138.

Van Oudenhove L. et al. Determinants of symptoms in functional dyspepsia: gastric sensorimotor function, psychosocial factors or somatisation? //Gut. 2008. Т. 57. №. 12. С. 1666–1673.

Vanuytsel T. et al. Psychological stress and corticotropin-releasing hormone increase intestinal permeability in humans by a mast cell-dependent mechanism //Gut. 2014. Т. 63. №. 8. С. 1293–1299.

Vlainic J. et al. Probiotics as an adjuvant therapy in major depressive disorder //Current neuropharmacology. 2016. Т. 14. №. 8. С. 952–958.

Wedding U. et al. Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy //Acta Oncologica. 2008. Т. 47. №. 1. С. 56–62.

Wu S. F. et al. Symptom Distress, Depression, and Quality of Life in Colorectal Cancer Patients at Different Disease Stages //Hu li za zhi The journal of nursing. 2015. Т. 62. №. 6. С. 68–80.

Zhang X. et al. Efficacy observation of periodic fecal microbiota transplantation in the treatment of refractory constipation //Zhonghua wei chang wai ke za zhi= Chinese journal of gastrointestinal surgery. 2017. Т. 20. №. 12. С. 1355–1359.

Zhou L. et al. Upregulation of blood proBDNF and its receptors in major depression //Journal of affective disorders. 2013. Т. 150. №. 3. С. 776–784.




DOI: https://doi.org/10.12731/wsd-2018-3-100-147

Ссылки

  • На текущий момент ссылки отсутствуют.




(c) 2018 Roman Aleksandrovich Bekker, Yuriy Vitalevich Bykov

Лицензия Creative Commons
Это произведение доступно по лицензии Creative Commons «Attribution-NonCommercial-NoDerivatives» («Атрибуция — Некоммерческое использование — Без производных произведений») 4.0 Всемирная.

ISSN 2072-0831 (print)

ISSN 2307-9428 (online)

                              

Контент доступен под лицензией Creative Commons Attribution-NonCommercial-NoDerivs 4.0.

HotLog Яндекс цитирования